Patients

With an ageing population, a number of cardiovascular diseases are becoming more prevalent. Despite its prevalence, there are still many cases of structural heart disease that are misdiagnosed. 

Echo IQ’s AI-powered solution brings a new level of assessment to healthcare professionals as they seek to identify life-threatening but treatable conditions, to bring treatment closer to patients and reduce the risk of misdiagnosis. Through these efforts, patients benefit from knowing that technology is being harnessed for maximum impact.

Conditions assessed include;

  • Aortic Stenosis (complete)
  • Heart Failure (Q3 2022)
  • Mitral Regurgitation (Q2 2023)
  • Pulmonary Hypertension and more (H2 2023)

This proprietary digital (cloud-based) solution is designed to show probality indicators for structural heart disease using echocardiographic measurement data from a standard cardiothoracic ultrasound. Our innovative diagnostic tool will analyse this data to generate a risk indicator. This will be augmented by an additional checks, alongside AI and machine learning.

MyEcho Insight is a tool for physicians and healthcare systems to support earlier identification of at-risk patients who may benefit from clinical review or more proactive vigilance. 
 

Request A Demo

ACCURACY IN RISK PREDICTION

Supports enhanced, accurate diagnosis methods

  • AI-powered risk assessments
  • Consistency, without bias

Reassurance knowing that human intelligence is supplemented by AI-driven technology backed by  hundreds of millions of cardiac data points. It is essential that we begin correcting the issues of misdiagnosis, and we believe that this screening process will allow us to do just that. With this technology, we aim to remove clinical bias and human error, thus improving the speed of identifying patients at risk.

REASSURANCE

We have access to over 2 million cardiac patient records.

  • Solutions validated against latest clinical guidelines
  • Algorithm validated on world’s largest database of its kind
Our innovative diagnostic tool will generate a risk assessment for structural heart disease using echocardiographic measurement data from a standard cardiothoracic ultrasound and will analyse this data to generate a risk indicator. We have exclusive access to NEDA’s medical database, which allows us to make use of over 200 million cardiac data points which aids in our solution, alongside AI and machine learning. NEDA is a highly trusted research database that collects echocardiographic measurements and associated health information from more than 35 leading hospitals. 

PEACE OF MIND

Helping provide diagnostic solutions for a disease that kills 18 million people each year.

  • Incorporates multiple variables
  • Generates alerts for action by healthcare professionals

Providing you with the peace of mind that all variables have been considered in order to deliver optimal care. MyEcho Insight has been designed to provide early, accurate and improved diagnosis of structural heart disease. With this technology, we aim to remove clinical bias and human error, thus improving the speed of identifying patients at risk.

Contact Us Today

Have any questions for us regarding our diagnostic tools? Feel free to get in touch with us.